The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal poorly differentiated neuroendocrine carcinoma: The NORDIC NEC study.
Halfdan Sorbye
No relevant relationships to disclose
Staffan Welin
No relevant relationships to disclose
Seppo W. Langer
No relevant relationships to disclose
Lene Weber Vestermark
No relevant relationships to disclose
Nanna Holt
No relevant relationships to disclose
Pia J. Osterlund
No relevant relationships to disclose
Svein Dueland
No relevant relationships to disclose
Eva Hofsli
No relevant relationships to disclose
Marianne Gronlie Guren
No relevant relationships to disclose
Katarina Ohrling
No relevant relationships to disclose
Elke Birkemeyer
No relevant relationships to disclose
Espen Thiis-Evensen
No relevant relationships to disclose
Matteo Biagini
No relevant relationships to disclose
Henning Gronbaek
Consultant or Advisory Role - Novartis
Leena-Maija Soveri
No relevant relationships to disclose
Ingrid Holst Olsen
No relevant relationships to disclose
Birgitte Federspiel
No relevant relationships to disclose
Joerg Assmus
No relevant relationships to disclose
Eva Tiensuu Janson
No relevant relationships to disclose
Ulrich Knigge
No relevant relationships to disclose